Salute e Benessere

Global Contract Pharmaceutical Manufacturing, Research, and Packaging Markets…

The global pharmaceutical contract manufacturing, research, and packaging market is a dynamic landscape poised for substantial growth from 2024 to 2029. BCC Research provides a comprehensive analysis, offering insights into market size starting from 2023 and projections through the next five years. The contract manufacturing segment is meticulously examined across various dimensions including product type, dosage form, drug molecule type, and delivery technologies across different regions…
PR Newswire
15/10/2024

Publication relating to transparency notifications

REGULATED INFORMATIONPublication relating to transparency notificationsMont-Saint-Guibert(Belgium), October 15, 2024 , 10:30 pm CET / 4:30 pm ET –In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received three transparency notifications as detailed below.Jürgen HambrechtOn October 15, 2024, Nyxoah received a transparency notification from...
Nasdaq GlobeNewswire
15/10/2024

Sanofi: Information concerning the total number of voting rights and shares -…

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of theCode de commerce(the French Commercial Code) and article 223-16 of theRèglement général de l'Autorité des Marchés Financiers(Regulation of the French stock market authority) Sanofi a Frenchsociété anonymewith a registered share capital of 2,537,214,304 € Registered office : 46, avenue de la Grande Armée - 75017 Paris - France Registered at the Paris...
Nasdaq GlobeNewswire
15/10/2024

Endo to Host Investor Call on Third-Quarter 2024 Financial Results

A replay of the webcast will be available within 24 hours at investor.endo.com. A replay of the webcast will be available within 24 hours atinvestor.endo.com. About EndoEndo is a diversified specialty pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more atwww.endo.comor...
PR Newswire
15/10/2024

MDisrupt Secures American Heart Association Ventures Investment, Enters…

In addition, MDisrupt will add new features to the marketplace platform through a strategic collaboration with the Association to meet the needs of its members, providing new ways for them to engage with the health technology, health services, medical device and life sciences sectors. This collaboration will enable members to advance the Association's mission of spreading evidence-based, high-quality scientific expertise across the healthcare ecosystem. In addition, MDisrupt will add new...
PR Newswire
15/10/2024

InSphero and FDA's NCTR Publish the Largest Benchmarking Study Demonstrating…

"Our work with the FDA's NCTR is a breakthrough in liver toxicology research and sets a new industry standard," said Dr. Jan Lichtenberg, CEO and Co-founder of InSphero. "The 152 FDA-approved compounds used for this study had all undergone classical preclinical and clinical safety testing, including studies in animals. Despite this, some compounds were later withdrawn due to liver safety concerns. We were able to correctly flag 80% of these withdrawn compounds using a…
PR Newswire
15/10/2024

Dreame enters UK market with the launch of flagship products

Founded in 2017, Dreame has quickly become a global leader in home cleaning technology, pioneering industry firsts. The company was the first to launch a robotic vacuum with a Robotic Flex Arm, designed to tackle hard-to-reach areas with ease. Dreame's innovation also extends to engineering the world's fastest digital motor at 200,000 RPM, delivering exceptional suction power for deeper, more efficient cleaning. Until this year, Dreame has made significant strides in the robotic vacuum market…
PR Newswire
15/10/2024

Spineway : Continued organic growth - Nine-month 2024 revenue of €9.1 million…

Press release Ecully, October 15, 2024 – 6 p.m. SPINEWAYContinued organic growth Nine-month 2024 revenue of €9.1 million (+21%)In thousands of euros 20242023Change %Q1 revenue3,0702,39828%Q2 revenue3,4653,03314%Q3 revenue2,5752,07724% 9M revenue9,1107,51021%Unaudited consolidated data The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, recorded an...
Nasdaq GlobeNewswire
15/10/2024

Casino Group: Appointment within Casino Group's central purchasing unit

Appointment within Casino Group's central purchasing unit Paris, 15 October 2024 Béatrice AVRIL has been appointed Head of Food and Non-Food Purchasing for the Group at Achats Marchandises Casino (AMC). Béatrice AVRIL, formerly Director of Private Label Food Purchasing, has been appointed Head of Food and Non-Food Purchasing for Casino Group at Achats Marchandises Casino (AMC). She will report to Hervé DAUDIN, Chairman of AMC and a member of Casino Group Executive Committee. This...
Nasdaq GlobeNewswire
15/10/2024

EUROAPI closes the financing of its FOCUS-27 plan

Press Release Paris - 15 October 2024 -EUROAPI today announces the closing of the refinanced Credit Revolving Facility (RCF) and the Perpetual Deeply Subordinated Hybrid Bond subscribed by Sanofi, thus completing the financing of its FOCUS-27 strategic plan. About EUROAPIEUROAPI is focused on reinventing active ingredient solutions to sustainably meet customers' and patients' needs around the world. We are a leading player in active pharmaceutical ingredients with...
Nasdaq GlobeNewswire
15/10/2024

Healthcare EDI Market to Hit USD 7.11 Billion by 2029 with 9.7% CAGR |…

Browse in-depth TOC on "Healthcare EDI Market" Browse in-depth TOC on "Healthcare EDI Market" 200 - Tables 50 - Figures 250 - Pages The rising shift towards the use of automated data validation with artificial intelligence (AI), cloud-based EDI solutions, the expansion of API-based plug-ins, and the increased adoption of blockchain technology to enhance security are expected to bolster the growth of the healthcare EDI market. Moreover, to promote health data...
PR Newswire
15/10/2024

PharmaMar Announces Positive and Statistically Significant Overall Survival and…

"The results of the Phase 3 IMforte trial are highly encouraging and showed a statistically significant benefit for the lurbinectedin and atezolizumab combination for extensive-stage small cell lung cancer patients receiving this treatment in the first-line maintenance setting. These results demonstrate the potential of this regimen to delay disease progression and extend survival for patients with this aggressive disease," said Rob Iannone, M.D., M.S.C.E., executive vice president…
PR Newswire
15/10/2024

Cell Based Assay Market Poised for Significant Growth, projected to Reach USD…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=201801 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=201801 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Cell Based Assay Market Overview Market Definition and Scope The Cell Based Assay Market refers to the segment of the pharmaceutical and biotechnology industries focused on testing cellular responses to various compounds,...
PR Newswire
15/10/2024

Cellular Health Screening & Health Testing Market Poised for Remarkable Growth…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1014477 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1014477 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Cellular Health Screening & Health Testing Market Overview Market Growth and Projections The Cellular Health Screening & Health Testing Market is experiencing rapid growth, driven by increasing consumer awareness...
PR Newswire
15/10/2024

Neurogenomics Market to Reach $4.68 Billion by 2031--Exclusive Report by…

Download FREE PDF Brochure Of Neurogenomics Market - Download FREE PDF Brochure Of Neurogenomics Market - https://www.meticulousresearch.com/download-sample-report/cp_id=6019 Neurogenomics is a multidisciplinary field that integrates genome sciences and neurobiology. It examines the genome's impact on the structure, evolution, development, and functionality of the nervous system. This research encompasses genetic analyses, including the assessment of genome sequencing outputs like...
PR Newswire
15/10/2024

Body Contouring Devices Market to Hit USD 3.00 Billion by 2029 with 11.4% CAGR |…

Browse in-depth TOC on "Body Contouring Devices Market" Browse in-depth TOC on "Body Contouring Devices Market" 349 - Tables 44 - Figures 309 - Pages By product, the body contouring devices market is segmented into non-invasive and invasive devices. In 2023, the non-invasive devices segment held the majority share in the body contouring devices market. The largest portion of non-invasive segment is driven by added benefits offered by the non-invasive device, predominantly...
PR Newswire
15/10/2024

Monument Therapeutics Secures £1M Investment to Fund Its Schizophrenia Programme…

Dr Randeep Grewal, who has served as a board observer at Monument representing angel investors since 2022, has been appointed as board Chair. Randeep brings extensive experience from his other roles as Chair of Bellevue Healthcare Trust and non-executive director of organisations including Hox Therapeutics, the Global Smaller Companies Trust and the Monks Investment Trust. Furthermore, his previous background as a fund manager and a vascular surgeon provides a unique blend of financial and…
PR Newswire
15/10/2024

Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne

"This achievement cannot be overstated," commented Christopher Carlton, Accure Acne, Inc.'s Co-Founder, Chairman of the Board and Chief Executive Officer. "After many years of rigorous technical, scientific, and clinical development, The Accure Laser has delivered yet another milestone achievement-the ability to provide a significant, sustained, and durable drug-free alternative for acne patients and their providers," continued Mr. Carlton. "This is the vision of Accure…
PR Newswire
15/10/2024

KFNCCC A Regional Leader in Pediatric Cancer Treatment

RIYADH, Saudi Arabia, Oct.15, 2024(GLOBE NEWSWIRE) -- At the heart of advanced medical efforts in pediatric oncology in the Kingdom, King Fahad National Centre for Children's Cancer (KFNCCC), affiliated with King Faisal Specialist Hospital & Research Centre (KFSHRC), stands as a unique healthcare institution in Saudi Arabia and the Middle East. Since its founding in 1997, the center has become a beacon of hope and medical innovation, operating within a comprehensive therapeutic...
Nasdaq GlobeNewswire
15/10/2024

Operation Smile Featured in "Beyond the Code," a New Branded Series that…

"We are proud to be part of Beyond the Code," said Dr. Billy Magee, Chief Medical Officer, Operation Smile. "The story produced for Operation Smile highlights our pioneering use of AI technology to enhance healthcare delivery. By integrating AI into our planning and evaluation processes, we are not only raising the standard of care but also building local capacity, bringing life-changing surgical care closer to the communities we serve." "We are proud to be part of…
PR Newswire
15/10/2024

Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing

Collaboration to Enable Sequencing of Cellular Biopsies Cytosurge's FluidFM ®OMNIUM platformwithLexogen's LUTHOR HDkit to offer a streamlined workflow that preserves cell viability, making live-cell sequencing more accessible and scalable for researchers. For more details,download the shared application note. Live-seq is a groundbreaking technology developed at ETH Zurich and EPFL, Switzerland, that allows the sequencing of a cell's transcriptome while keeping the cell alive...
Nasdaq GlobeNewswire
15/10/2024

Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing

Live-seq is a groundbreaking technology developed at ETH Zurich and EPFL, Switzerland, that allows the sequencing of a cell's transcriptome while keeping the cell alive. This represents a paradigm shift from traditional methods that kill cells during sampling, providing new opportunities for dynamic, time-resolved transcriptomic studies. Cytosurge's FluidFM® technology enables gentle extraction of cytoplasmic biopsies without harming the cell. Extremely low amounts of RNA (typically <1 pg) in…
PR Newswire
15/10/2024

Major shareholder announcement

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments.Per October 11, 2024, BlackRock, Inc. has adjusted its holding of shares to an equivalent of 23,045,290 shares, corresponding to 4.92% (previously 4.95%) of the total share capital attached to shares. The combined total of share...
Nasdaq GlobeNewswire
15/10/2024

Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date…

BOSTON and LONDON, Oct.15, 2024(GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, announces the effectiveness of the Form S-4, originally filed with the SEC on September 13, 2024 related to the merger of Akari Therapeutics, Plc (the Company) and Peak Bio, Inc. The Form S-4 was declared effective by the SEC on October 11, 2024 allowing the Company to definitively schedule the...
Nasdaq GlobeNewswire
15/10/2024
Altri  Comunicati